{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,26]],"date-time":"2025-07-26T09:19:00Z","timestamp":1753521540785},"reference-count":25,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2009,1,1]],"date-time":"2009-01-01T00:00:00Z","timestamp":1230768000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["La Presse M\u00e9dicale"],"published-print":{"date-parts":[[2009,1]]},"DOI":"10.1016\/j.lpm.2008.10.009","type":"journal-article","created":{"date-parts":[[2009,3,11]],"date-time":"2009-03-11T16:08:12Z","timestamp":1236787692000},"page":"117-124","source":"Crossref","is-referenced-by-count":6,"title":["Ad\u00e9nomes \u00e0 prolactine\u00a0: diagnostic et prise en charge"],"prefix":"10.1016","volume":"38","author":[{"given":"Brigitte","family":"Delemer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.lpm.2008.10.009_bib1","series-title":"The pituitary","first-page":"455","article-title":"Prolactinoma","author":"Molitch","year":"2002"},{"key":"10.1016\/j.lpm.2008.10.009_bib2","doi-asserted-by":"crossref","first-page":"4769","DOI":"10.1210\/jc.2006-1668","article-title":"High prevalence of pituitary adenomas: a cross-sectional study in the province of Li\u00e8ge, Belgium","volume":"91","author":"Daly","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.lpm.2008.10.009_bib3","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ando.2006.11.001","article-title":"Diagnosis and management of hyperprolactinemia: expert consensus - French society of endocrinology","volume":"68","author":"Brue","year":"2007","journal-title":"Ann Endocrinol"},{"key":"10.1016\/j.lpm.2008.10.009_bib4","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1210\/jc.82.7.2102","article-title":"Sex-related difference in the growth of prolactinomas: a clinical and proliferation marker study","volume":"82","author":"Delgrange","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.lpm.2008.10.009_bib5","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1530\/eje.1.02339","article-title":"What are the markers of aggressiveness in prolactinomas? Changes in cell biology, extracellular matrix compnents, angiogenesis and genetics","volume":"156","author":"Gurlek","year":"2007","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.lpm.2008.10.009_bib6","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.ecl.2007.10.013","article-title":"Hyperprolactinemia and Prolactinomas","volume":"37","author":"Mancini","year":"2008","journal-title":"Endocrinol Metab Clin N Am"},{"key":"10.1016\/j.lpm.2008.10.009_bib7","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1530\/EJE-07-0348","article-title":"The clinical, pathological, and genetic features of familial isolated pituitary adenomas","volume":"157","author":"Beckers","year":"2007","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.lpm.2008.10.009_bib8","doi-asserted-by":"crossref","first-page":"E665","DOI":"10.1152\/ajpendo.1998.274.4.E665","article-title":"On the mechanism of lactational anovulation in the rhesus monkey","volume":"274","author":"\u00d6rd\u00f6g","year":"1998","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.lpm.2008.10.009_bib9","doi-asserted-by":"crossref","first-page":"5410","DOI":"10.1210\/jc.2001-011943","article-title":"Gross variability in the detection of prolactin in sera containing big big prolactin (macroprolactin) by commercial immunoassays","volume":"87","author":"Smith","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.lpm.2008.10.009_bib10","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.ando.2006.10.002","article-title":"The use of intravenous catheterisation with a rest period is useful for determination of plasma cortisol levels but not plasma prolactin levels","volume":"68","author":"Briet","year":"2007","journal-title":"Annal Endocrinol"},{"key":"10.1016\/j.lpm.2008.10.009_bib11","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1111\/j.1365-2265.2006.02627.x","article-title":"Do the limits of serum prolactin in disconnection hyperprolactinaemia need re-definition? A study of 226 patients with histologically verified non-functioning pituitary macroadenoma","volume":"65","author":"Karavitaki","year":"2006","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.lpm.2008.10.009_bib12","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.ando.2007.03.013","article-title":"Etiological diagnosis of hyperprolactinemia","volume":"68","author":"Cortet-Rudelli","year":"2007","journal-title":"Ann Endocrinol"},{"key":"10.1016\/j.lpm.2008.10.009_bib13","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1210\/er.2005-9998","article-title":"Advances in the treatment of prolactinomas","volume":"27","author":"Gilliam","year":"2006","journal-title":"Endocr Rev"},{"key":"10.1016\/j.lpm.2008.10.009_bib14","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1210\/edrv-13-2-220","article-title":"Dopamine agonists and pituitary tumor shrinkage","volume":"13","author":"Bevan","year":"1992","journal-title":"Endocr Rev"},{"key":"10.1016\/j.lpm.2008.10.009_bib15","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1210\/jc.84.7.2518","article-title":"Cabergoline in the treatment of hyperprolactinemia: a study in 455 patients","volume":"84","author":"Verhelst","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.lpm.2008.10.009_bib16","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1056\/NEJMoa062222","article-title":"Dopamine agonists and the risk of cardiac-valve regurgitation","volume":"356","author":"Schade","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lpm.2008.10.009_bib17","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1056\/NEJMoa054830","article-title":"Valvular heart disease and the use of dopamine agonists for Parkinson's disease","volume":"356","author":"Zanettini","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lpm.2008.10.009_bib18","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1530\/EJE-08-0611","article-title":"Cabergoline and cardiac valve disease in prolactinoma patients: additional studies during long-term treatment are required","volume":"159","author":"Kars","year":"2008","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.lpm.2008.10.009_bib19","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1056\/NEJMoa022657","article-title":"Withdrawal of long-term cabergoline therapy for tumoral and nontumoral hyperprolactinemia","volume":"349","author":"Colao","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lpm.2008.10.009_bib20","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ando.2007.03.008","article-title":"Prolactinoma and estrogens: pregnancy, contraception and hormonal replacement therapy","volume":"68","author":"Christin-Maitre","year":"2007","journal-title":"Ann Endocrinol"},{"key":"10.1016\/j.lpm.2008.10.009_bib21","first-page":"1121","article-title":"Management of prolactinomas during pregnancy","volume":"44","author":"Molitch","year":"1999","journal-title":"J Reprod Med"},{"key":"10.1016\/j.lpm.2008.10.009_bib22","doi-asserted-by":"crossref","first-page":"S38","DOI":"10.1016\/S1096-6374(03)00054-6","article-title":"Pituitary tumors and pregnancy","volume":"13","author":"Molitch","year":"2003","journal-title":"Growth Hormone & IGF Research"},{"key":"10.1016\/j.lpm.2008.10.009_bib23","first-page":"2117","article-title":"La grossesse, une modalit\u00e9 de gu\u00e9rison des ad\u00e9nomes \u00e0 PRL\u00a0? Dix huit observations","volume":"17","author":"Bricaire","year":"1998","journal-title":"Presse Med"},{"key":"10.1016\/j.lpm.2008.10.009_bib24","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1111\/j.1365-2265.2007.03000.x","article-title":"Pregnancy outcomes following cabergoline treatment: extended results from a 12-year observational study","volume":"68","author":"Colao","year":"2008","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.lpm.2008.10.009_bib25","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1530\/eje.0.1350413","article-title":"Prolactinomas resistant to bromocriptine: long-term efficacy of quinagolide and outcome of pregnancy","volume":"135","author":"Morange","year":"1996","journal-title":"Eur J Endocrinol"}],"container-title":["La Presse M\u00e9dicale"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0755498208006131?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0755498208006131?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,18]],"date-time":"2019-05-18T13:01:45Z","timestamp":1558184505000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0755498208006131"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,1]]}},"alternative-id":["S0755498208006131"],"URL":"https:\/\/doi.org\/10.1016\/j.lpm.2008.10.009","relation":{},"ISSN":["0755-4982"],"issn-type":[{"value":"0755-4982","type":"print"}],"subject":[],"published":{"date-parts":[[2009,1]]}}}